Zdrowie i gospodarka · 27/12/2013

FDA Extends Comment Period for Proposed Rule on Drug Labeling Changes

The Food and Drug Administration (FDA) is extending the comment period for a proposed rule regarding changes to approved drug and biological product labels, following a request for an extension from interested parties. The rule, initially published in 2013, aimed to clarify procedures for product labeling changes in advance of FDA review.